主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MGNX
#3182
MacroGenics, Inc.
1.9
9
+1.53%
版块:
基础:
利润货币:
日范围
年范围
日变化
+1.53%
每月变动
+8.15%
6个月变化
+13.71%
年变化
-17.43%
前一天收盘价
1.9
6
Open
1.9
9
Bid
Ask
Low
1.9
9
High
1.9
9
交易量
16
市场
股票
医疗保健
MGNX
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
62.76 M
63.09 M
63.09 M
63.21 M
63.26 M
—
Valuation ratios
Enterprise value
26.87 M
22.2 M
-65.45 M
-54.21 M
26.15 M
-71.3 M
Price to earnings ratio
-2.1
-3.04
-1.44
-2.16
-1.41
-8.05
Price to sales ratio
1.46
1.36
0.52
0.46
0.83
3.17
Price to cash flow ratio
-3.51
-2.98
-1.14
-1.06
-0.65
-5.83
Price to book ratio
0.47
1.75
0.21
0.21
0.34
2.52
Enterprise value to EBITDA ratio
0.29
0.26
-0.7
-0.49
0.34
-0.59
Profitability ratios
Return on assets %
0.21
-0.37
0.18
0.15
0.06
0.02
Return on equity %
0.47
-0.84
0.52
0.78
0.25
0.71
Return on invested capital %
—
-2 197.92
—
193.79
59.56
—
Gross margin %
99.85
98.8
100
100
100
398.8
Operating margin %
48.95
-287
323.1
165.27
25.59
226.96
EBITDA margin %
88.77
-34.3
32.18
66.75
88.86
153.49
Net margin %
50.86
-502.23
311.07
162.99
23.09
-5.08
Liquidity ratios
Quick ratio
3.69
3.92
3.11
5.02
5.02
17.07
Current ratio
3.75
3.92
3.28
5.25
5.22
17.68
Inventory turnover
0.08
0.14
0
0
0
0.14
Asset turnover
0.48
0.07
0.05
0.09
0.28
0.5
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.96
0.61
0.74
0.74
0.48
2.58
EBIT per share
1.53
-0.14
0.04
0.2
0.99
1.1
EBITDA per share
1.56
-0.11
0.07
0.24
1.02
1.22
Total debt per share
—
—
—
—
—
—
Cash per share
2.86
2.92
2.31
2.07
1.27
8.57
Net current asset value per share
3.53
3.47
2.89
3.25
3.67
13.28
Tangible book value per share
1.91
1.85
1.26
0.74
1.06
4.91
Working capital per share
2.59
2.59
2.01
2.63
2.96
10.19
Book value per share
1.91
1.85
1.26
0.74
1.06
4.91
新闻
BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates
FDA部分临床暂停后MacroGenics股价下跌
MacroGenics stock falls after FDA places partial clinical hold
Why Is MacroGenics Stock Sinking Tuesday? - Macrogenics (NASDAQ:MGNX)
Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes
FDA Accepts SNY Filing for Expanded Use of T1D Drug in Young Children
Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3
MacroGenics (MGNX) Q3 Earnings and Revenues Surpass Estimates
MacroGenicsQ3每股收益及营收超出预期
MacroGenics Inc earnings beat by $0.68, revenue topped estimates
MacroGenics (MGNX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Stryker (SYK) Q3 Earnings and Revenues Beat Estimates